Prognostic Value of the Progesterone Receptor by Subtype in Patients with Estrogen Receptor‐Positive, HER‐2 Negative Breast Cancer

BACKGROUND. In estrogen receptor‐positive (ER+), human epidermal growth factor receptor 2 (HER‐2) negative breast cancers, the progesterone receptor (PR) is an independent prognostic marker. Little is known about the prognostic value of PR by tumor grade. We assessed this in two independent datasets...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncologist
Autors principals: Van Asten, Kathleen, Slembrouck, Laurence, Olbrecht, Siel, Jongen, Lynn, Brouckaert, Olivier, Wildiers, Hans, Floris, Giuseppe, Van Limbergen, Erik, Weltens, Caroline, Smeets, Ann, Paridaens, Robert, Giobbie‐Hurder, Anita, Regan, Meredith M., Viale, Giuseppe, Thürlimann, Beat, Vergote, Ignace, Christodoulou, Evangelia, Van Calster, Ben, Neven, Patrick
Format: Artigo
Idioma:Inglês
Publicat: John Wiley & Sons, Inc. 2018
Matèries:
Breast Cancer
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6369957/
https://ncbi.nlm.nih.gov/pubmed/30171067
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2018-0176
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars